Ranibizumab for Macular Edema Secondary to RVORanibizumab for Macular Edema Secondary to RVO

A new study compares the efficacy of different doses of ranibizumab for macular edema secondary to RVO -- and whether the addition of non-anti-VEGF treatment provides any additional benefits. BMC Ophthalmology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news